Lymphoproliferative Disorders in Patients with Systemic Lupus Erythematosus

Panizo, Carlos; García‐Muñoz, Ricardo

doi:10.5772/28507

Search citation statements

Order By: Relevance

Paper Sections

Select...

Figure1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(2 citation statements)

References 123 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pathophysiology of PCMZL remains unclear 7 . It is thought to be driven by chronic immune responses to pathogens or auto‐antigens 2,5,8 …”

Section: Figurementioning

confidence: 99%

“…2,5,8 Treatment of PCMZL in SLE patients does not differ from that administered to patients without SLE 8 While regression of localized PCMZL associated with microbial pathogens can be achieved with antibiotic therapy, persistent infection or resistant lymphoma may require conventional oncologic modalities. 8 The choice of therapy should be tailored to individual patients depending on the site, extension of the lesion and patients' comorbidities. 9 In solitary or localized PCMZL, surgical excision and local radiotherapy are the mainstays of treatment.…”

mentioning

confidence: 99%

See 1 more Smart Citation